Evidence map›Paper›PMID 42507081›Full record

ArticleClinical and experimental nephrology2026

Peroxidasin expression patterns predict fibrosis and kidney function decline in IgA nephropathy.

Roberto Silva, Isabel Brandão, Tony J Chen, Hans-Peter Marti, Bárbara Gomes, Bernardo Faria, Manuel Pestana, Jorge R Almeida, Inês S Alencastre, João Paulo Oliveira

Abstract read
In one paragraph

Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roberto Silva *Department of Anatomic Pathology, São João Local Health Unit and University Hospital, Porto, Portugal.
Isabel Brandão *i3S - Instituto de Investigação e Inovação em Saúde (i3S - Institute for Research and Innovation in Health), University of Porto, Porto, Portugal.
Tony J ChenDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Hans-Peter MartiDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Bárbara GomesDepartment of Anatomic Pathology, São João Local Health Unit and University Hospital, Porto, Portugal.
Bernardo FariaFaculty of Medicine, University of Porto, Porto, Portugal.
Manuel PestanaFaculty of Medicine, University of Porto, Porto, Portugal.
Jorge R Almeidai3S - Instituto de Investigação e Inovação em Saúde (i3S - Institute for Research and Innovation in Health), University of Porto, Porto, Portugal.
Inês S Alencastre *Faculty of Medicine, University of Porto, Porto, Portugal. ialencastre@med.up.pt.ORCID https://orcid.org/0000-0002-5591-5596
João Paulo Oliveira *Department of Anatomic Pathology, São João Local Health Unit and University Hospital, Porto, Portugal. jpo@med.up.pt.ORCID http://orcid.org/0000-0002-5016-1967

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxidasin (PXDN), a heme-containing peroxidase involved in basement membrane assembly, has been increasingly implicated in fibrotic processes, yet its role in kidney disease remains unclear. We therefore characterized PXDN expression in kidney biopsies from patients with IgA nephropathy (IgAN), a leading cause of CKD, and assessed its association with fibrosis. Immunofluorescence demonstrated widespread PXDN expression across renal compartments, with predominant localization in distal tubules, consistent with healthy tissue. In contrast, PXDN expression was reduced in proximal tubules, including non-atrophic segments, and markedly increased in the fibrotic interstitium. PXDN strongly correlated with collagen III deposition in sclerotic glomeruli and fibrotic interstitium, but not with collagen IV. Clinically, patients with impaired kidney function (eGFR < 60 ml/min/1.73 m²) exhibited higher PXDN expression in glomeruli, proximal tubules, and fibrotic interstitium, with glomerular PXDN inversely correlating with eGFR. These findings reveal compartment-specific alterations in PXDN expression in IgAN, associated with interstitial fibrosis, collagen III deposition, and declining kidney function. PXDN may participate in fibrotic remodeling processes and represents a potential therapeutic target, warranting further investigation in CKD progression.

Indexed as

Extracellular Matrix ProteinsGlomerulonephritis, IGAKidneyPeroxidasePeroxidasesAdultBiopsyCollagen Type IIIDisease ProgressionFemaleFibrosisGlomerular Filtration RateHumansKidney GlomerulusMaleMiddle AgedCollagen Type IIIExtracellular Matrix ProteinsPeroxidasePeroxidasesPeroxidasinPXDN protein, humanChronic kidney disease progressionCollagen type IIICompartment-specific expression: IgA NephropathyInterstitial fibrosisPeroxidasinRenal fibrogenesis

Identifiers

PMID42507081
PMCPMC13669128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.